Humacyte shareholders approve authorized shares increase to 350M, elect directors

Humacyte, Inc.

Authorized common shares raised from 250M to 350M; vote 82.6M for, 14.1M against.
Four Class I directors elected: Dougan, Green, Seimetz, Wallace (each with >56M votes).
PwC ratified as auditor for FY2025 (95.3M for, 2.0M against, 0.6M abstain).
Annual meeting quorum 63.1% (97.9M of 155.1M shares outstanding present).

item 5.03item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.